Literature DB >> 22498834

Pain in neurological conditions.

Paul R Nandi1.   

Abstract

PURPOSE OF REVIEW: To address the issues of the scale and diversity of chronic pain in neurological disorders and the evidence for effective treatment of pain in these conditions. RECENT
FINDINGS: Contemporary literature supports the notion that pain in neurological conditions is common and has tended to be underestimated.
SUMMARY: Pain in neurological disease displays great diversity in putative mechanisms and clinical presentation. Rational management requires an analysis of likely mechanisms of pain generation as a guide to treatment. Some common neurological disorders are briefly discussed, primarily to provide an indication of the range of pain phenotypes observed across the spectrum of neurological disease. Treatments are reviewed with an emphasis on systemic drugs and the current best evidence for their use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498834     DOI: 10.1097/SPC.0b013e328352edff

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  3 in total

1.  Clinical use of blood flow restriction in people with neurologic conditions: a cross-sectional survey.

Authors:  Mark M Mañago; Kyle Kimbrell; Emily R Hager; Hannah Dwight; Johnny Owens; Michael Bade
Journal:  J Phys Ther Sci       Date:  2022-04-08

Review 2.  Understanding the Impact of Brain Disorders: Towards a 'Horizontal Epidemiology' of Psychosocial Difficulties and Their Determinants.

Authors:  Alarcos Cieza; Marta Anczewska; Jose Luis Ayuso-Mateos; Mary Baker; Jerome Bickenbach; Somnath Chatterji; Sally Hartley; Matilde Leonardi; Tuuli Pitkänen
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 3.  Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?

Authors:  Caroline M Freitag; Richard J Miller
Journal:  Front Cell Neurosci       Date:  2014-08-20       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.